
Week in Review: Third Quarter 2012 Venture-Backed IPOs Double Year Over Year
The third quarter is officially under our belts, and the first venture capital numbers are already out. Ten venture-backed IPOs raised $1.1 billion in the…
Posted by
The third quarter is officially under our belts, and the first venture capital numbers are already out. Ten venture-backed IPOs raised $1.1 billion in the…
Posted by
This morning, I was at The New York Stock Exchange, where I participated on a panel at IR Magazine’s Think Tank – East Coast 2012,…
Posted by
On Tuesday, October 9, 2012, Safeguard will host its 6th annual Investor Day at The Yale Club of New York City from 8:30a.m. – 11:30a.m. Here’s an…
Posted by
The municipal bond market is a thicket of data that can be outdated and doesn’t conform to a standard format, leaving investment firms to spend…
Posted by
Over the past twelve months, there has been a significant shift in investor behavior. Today, investors are putting money to work in “safe havens” such…
Posted by
Good ideas are a dime a dozen. Anyone can come up with a good idea. What separates ideas from businesses—and success—is execution. Consider Thomas Edison.…
Posted by
Last week, Safeguard Scientifics’ healthcare IT partner company, AdvantEdge Healthcare Solutions (AdvantEdge) presented at the William Blair & Company’s 15th Annual Private Equity Conference in Chicago,…
Posted by
The patent fights that have erupted this year—Apple versus Samsung, Yahoo versus Facebook—aren’t limited to big, established companies. A recent Reuters report draws attention to…
Posted by
A recent article in Harvard Business Review pointed to the human genome as the next focus for diagnosing and treating diseases. The authors call for…
Posted by